Untitled

Abstract

During the last three decades technical advances and the introduction of new, radiation free modalities have allowed a less restrictive use of imaging. Combining different low-or no radiation modalities as appropriate affords a unique opportunity to undertake large-scale, population based longitudinal research examining the prevalence, natural history and the effectiveness of treatment for a variety of diseases. In this paper we address the use of imaging in epidemiological studies of developmental hip dysplasia (DDH) based on work performed at Haukeland University Hospital since 1987, and since 2006 in collaboration with MRC Centre of Epidemiology for Child Health, UCL Institute of Child Health, London. This lifecourse approach to investigating phenotypes for, risk factors for, and outcomes of DDH is novel (1).

What Is the Optimal Strategy To Screen for Hip Dysplasia?

“…1 Most of these represent mild dysplasia, which is expected to resolve spontaneously, or false positive hip US examinations. The best screening strategy was determined to be universal PE/selective US screening.…”